Retatrutide, a new weight loss medication, works by mimicking the hormones in the body that regulate hunger and fullness. Specifically, it is designed to function similarly to three key hormones: glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon.
This triple action approach of Retatrutide may be the reason behind its significant success in promoting weight loss, according to Dr. Dan Skovronsky, the chief scientific and medical officer at Eli Lilly.
By mimicking these hormones, Retatrutide can help individuals prevent overeating, reduce their food intake, and reach a feeling of fullness. Rather than relying on drastic measures like forced thermogenesis or ketosis, this medication offers a more straightforward approach to weight loss.
In addition to curbing appetite, Retatrutide also works to suppress cravings and hunger signals that can lead to unhealthy eating habits or cravings for unhealthy foods. Overall, its unique mechanism of action makes it a promising option for those looking to manage their weight more effectively.
